Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations
DTG/3TC showed high efficacy in participants with tRAMs not affecting this regimen. The detection of such tRAMs did not compromise treatment outcomes in treatment-naïve individuals in this setting.
Authors
- Gisela Arevalo Calderon
- Ezequiel Córdova
- Soledad Seleme
- Norma Porteiro
- Veronica Mingrone
- Jenifer Hernandez Rendon
Institutions
- Fundación para la Investigación, Docencia y Prevención del Cáncer (AR)
Publication Details
- Journal
- AIDS
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1097/qad.0000000000004444
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00